Assessment of Primary Hemostasis by PFA-100® Analysis in a Tertiary Care Center
- 1 January 2000
- journal article
- editorial
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 84 (07) , 93-97
- https://doi.org/10.1055/s-0037-1613974
Abstract
We evaluated the utility of the PFA-100® platelet function analyzer in identifying disorders in platelet function and/or von Willebrand factor (vWF) in patients with various systemic disorders being followed at a tertiary care center. Closure times were determined with collagen/ ADP (CADP) and collagen/epinephrine (CEPI) cartridges for 305 patients, and abnormal results were further evaluated with platelet aggregometry and vWF analysis. Prolonged CADP and/or CEPI closure times were identified in 114 patients (37.3%), but most were isolated prolonged CEPI closure times predominantly due to aspirin therapy (79 patients). Prolonged CADP closure times were most frequently due to qualitative platelet defects and/or decreased vWF levels. Prolonged CADP closure times were encountered most frequently in patients with sickle cell disease and were associated with a decreased hematocrit. This study demonstrated that the PFA-100® analyzer can accurately assess vWF-dependent platelet function and detect other platelet defects under high shear stress in complex patient populations.Keywords
Funding Information
- Dade Behring Inc
This publication has 8 references indexed in Scilit:
- von Willebrand FactorPublished by Wiley ,2002
- Evaluation of Platelet Function with the PFA-100 System in Patients with Congenital Defects of Platelet SecretionThrombosis Research, 1999
- A comparison of the effects of aspirin on bleeding time measured using the Simplate™ method and closure time measured using the PFA‐100™, in healthy volunteersBritish Journal of Clinical Pharmacology, 1997
- Hemostasis in renal disease: Pathophysiology and managementThe American Journal of Medicine, 1994
- Von Willebrand Factor: Clinical Features of Inherited and Acquired DisordersMayo Clinic Proceedings, 1991
- Platelet dysfunction associated with wilms tumor and hyaluronic acidAmerican Journal of Hematology, 1987
- Platelet function in the myelodysplastic syndromesScandinavian Journal of Haematology, 1986
- A plasma inhibitor of ristocetin-induced platelet aggregation in patients with sickle hemoglobinopathiesAmerican Journal of Hematology, 1977